durapatite has been researched along with ibandronic acid in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bauss, F; Eberhardt, C; Kurth, AH; Müller, S; Schwarz, M; Steinacker, M | 1 |
Bauss, F; Eberhardt, C; Habermann, B; Kurth, AH; Müller, S; Schwarz, M | 1 |
Bao, C; Gao, Y; Hu, J; Liu, X; Zou, S | 1 |
Henry, C; Jahnke, W | 1 |
Chaurasia, S; Di Stilo, A; Ferracini, R; Fruttero, R; Gasco, A; Gorassini, E; Lazzarato, L; Lolli, ML; Oliaro-Bosso, S; Rolando, B; Tosco, P | 1 |
Shiraishi, A | 1 |
1 review(s) available for durapatite and ibandronic acid
Article | Year |
---|---|
[Pharmacological profile and clinical evidence in patients with primary osteoporosis treated with intravenous ibandronate].
Topics: Animals; Bone and Bones; Bone Density; Bone Density Conservation Agents; Cholecalciferol; Diphosphonates; Disease Models, Animal; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Durapatite; Haplorhini; Humans; Ibandronic Acid; Infusions, Intravenous; Osteoporosis; Randomized Controlled Trials as Topic; Rats; Spinal Fractures | 2014 |
5 other study(ies) available for durapatite and ibandronic acid
Article | Year |
---|---|
The bisphosphonate ibandronate improves implant integration in osteopenic ovariectomized rats.
Topics: Animals; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Diphosphonates; Durapatite; Female; Femur; Ibandronic Acid; Osseointegration; Osteoporosis; Ovariectomy; Prostheses and Implants; Rats; Rats, Sprague-Dawley; Titanium | 2005 |
The bisphosphonate ibandronate accelerates osseointegration of hydroxyapatite-coated cementless implants in an animal model.
Topics: Animals; Bone Density Conservation Agents; Coated Materials, Biocompatible; Diphosphonates; Disease Models, Animal; Durapatite; Female; Femoral Fractures; Ibandronic Acid; Injections, Subcutaneous; Osseointegration; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2007 |
The effect of surface immobilized bisphosphonates on the fixation of hydroxyapatite-coated titanium implants in ovariectomized rats.
Topics: Absorptiometry, Photon; Animals; Biomechanical Phenomena; Bone Density; Coated Materials, Biocompatible; Diphosphonates; Durapatite; Female; Ibandronic Acid; Imidazoles; Implants, Experimental; Microscopy, Electron, Scanning; Ovariectomy; Pamidronate; Rats; Rats, Sprague-Dawley; Surface Properties; Tibia; Titanium; X-Ray Microtomography; Zoledronic Acid | 2009 |
An in vitro assay to measure targeted drug delivery to bone mineral.
Topics: Alendronate; Anabolic Agents; Bone and Bones; Bone Density Conservation Agents; Diphosphonates; Drug Delivery Systems; Durapatite; Etidronic Acid; Humans; Ibandronic Acid; Imidazoles; Nuclear Magnetic Resonance, Biomolecular; Pamidronate; Risedronic Acid; Zoledronic Acid | 2010 |
Synthesis and preliminary pharmacological characterisation of a new class of nitrogen-containing bisphosphonates (N-BPs).
Topics: Animals; Aorta, Thoracic; Bone and Bones; Bone Density Conservation Agents; Cells, Cultured; Chromatography, Affinity; Diphosphonates; Durapatite; Farnesyl-Diphosphate Farnesyltransferase; Humans; Ibandronic Acid; In Vitro Techniques; Macrophages; Magnetic Resonance Spectroscopy; Male; Mice; Microsomes, Liver; Models, Molecular; Muscle, Smooth, Vascular; Nitric Oxide Donors; Nitrogen; Osteogenesis; Rats; Rats, Wistar; Vasodilator Agents | 2010 |